Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells.

Autor: Mayengbam SS; National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India., Singh A; National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India., Yaduvanshi H; National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India., Bhati FK; National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India., Deshmukh B; National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India., Athavale D; National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India., Ramteke PL; National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India., Bhat MK; National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India. manojkbhat@nccs.res.in.
Jazyk: angličtina
Zdroj: Cancer & metabolism [Cancer Metab] 2023 Sep 13; Vol. 11 (1), pp. 15. Date of Electronic Publication: 2023 Sep 13.
DOI: 10.1186/s40170-023-00315-1
Abstrakt: Hypercholesterolemia is often correlated with obesity which is considered a risk factor for various cancers. With the growing population of hypercholesterolemic individuals, there is a need to understand the role of increased circulatory cholesterol or dietary cholesterol intake towards cancer etiology and pathology. Recently, abnormality in the blood cholesterol level of colon cancer patients has been reported. In the present study, we demonstrate that alteration in cholesterol levels (through a high-cholesterol or high-fat diet) increases the incidence of chemical carcinogen-induced colon polyp occurrence and tumor progression in mice. At the cellular level, low-density lipoprotein cholesterol (LDLc) and high-density lipoprotein cholesterol (HDLc) promote colon cancer cell proliferation by tuning the cellular glucose and lipid metabolism. Mechanistically, supplementation of LDLc or HDLc promotes cellular glucose uptake, and utilization, thereby, causing an increase in lactate production by colon cancer cells. Moreover, LDLc or HDLc upregulates aerobic glycolysis, causing an increase in total ATP production through glycolysis, and a decrease in ATP generation by OXPHOS. Interestingly, the shift in the metabolic status towards a more glycolytic phenotype upon the availability of cholesterol supports rapid cell proliferation. Additionally, an alteration in the expression of the molecules involved in cholesterol uptake along with the increase in lipid and cholesterol accumulation was observed in cells supplemented with LDLc or HDLc. These results indicate that colon cancer cells directly utilize the cholesterol associated with LDLc or HDLc. Moreover, targeting glucose metabolism through LDH inhibitor (oxamate) drastically abrogates the cellular proliferation induced by LDLc or HDLc. Collectively, we illustrate the vital role of cholesterol in regulating the cellular glucose and lipid metabolism of cancer cells and its direct effect on the colon tumorigenesis.
(© 2023. BioMed Central Ltd., part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: